Recent research suggests that acid reflux medications could potentially trigger migraines. Scientists have identified a higher risk of experiencing severe headaches among individuals who use acid-reducing tablets compared to those who do not. These medications include proton pump inhibitors (PPIs) like omeprazole and esomeprazole, histamine H2-receptor antagonists (H2 blockers) such as cimetidine and famotidine, as well as antacid supplements.
However, it is important to note that the study does not definitively establish a causal relationship between acid-reducing drugs and migraines; it only demonstrates an association. Acid reflux occurs when stomach acid flows back into the esophagus, typically after eating or while in a reclined position.
Individuals with acid reflux may experience symptoms like heartburn and ulcers, and persistent acid reflux can progress to gastroesophageal reflux disease (GERD), which may elevate the risk of esophageal cancer. Professor Margaret Slavin from the University of Maryland emphasized the need for further investigation into the potential link between acid-reducing drugs and migraines due to the widespread use of these medications and their potential implications.
The study examined data from over 11,800 participants who reported their use of prescribed acid-reducing medications and their history of migraines or severe headaches in the preceding three months. Among those taking PPIs, 25% reported migraines or severe headaches, in contrast to 19% of non-users. Similarly, 25% of individuals using H2 blockers experienced severe headaches compared to 20% of non-users, while 22% of those taking antacid supplements reported severe headaches compared to 20% of non-users.
After adjusting for various factors that could influence migraine risk, such as age, gender, caffeine, and alcohol consumption, researchers discovered that individuals using PPIs were 70% more likely to have migraines, those using H2 blockers were 40% more likely, and those using antacid supplements were 30% more likely. These findings were published in the journal Neurology Clinical Practice.
Professor Slavin emphasized that while some individuals may require acid-reducing medications for managing acid reflux or other conditions, those experiencing migraines or severe headaches while taking these medications should consult their healthcare providers regarding the need to continue treatment. Previous studies have suggested a potential association between gastrointestinal conditions and migraines, but the relationship does not fully elucidate the connection observed in this study.
